FY16 EPS is only going to 6 (best case estimates factoring in the recent Ibuforen numbers). At 30PE upside is capped at 180. It’s already run-up too fast to 160 odd levels. There is going to be a lot of time now for the stock to consolidate and FII’s to nibble into slowly. Also gives us the opportunity to add more…
| Subscribe To Our Free Newsletter |
